Introduction
Family Herpesviridae represents a diverse group of large-DNA icosahedral viruses with widespread host distribution throughout animal lineages, including avian, mammalian, and reptilian hosts (Davison et al., 2009) . Extensive efforts to classify associations between herpesvirus and host have produced three broad groupings: alpha-, beta-and gamma-herpesvirus. Of herpesviruses, Alphaherpesviruses are the most specieous, widely distributed amongst host species (Davison, 2000) , and tend to coevolve with their hosts (Severini et al., 2013; McGeoch et al., 2000) . This coevolution consequently leads to specialization on hosts, resulting in lethal spillover events (Huff and Barry, 2003; Huemer et al., 2002) , host-specific transmission routes (including sexual, mechanical, and vectored), and system-specific host symptoms (Whitley and Roizman, 2001a; Gershon et al., 2015) . Of note, Alphaherpesviruses are frequently implicated in tumorigenesis of host tissues (Goldberg, 1981; Whitley and Roizman, 2001b) . Herpesviruses, such as Epstein-Barr, frequently cause large chromosomal rearrangements when inserting into host genomes (Gerber et al., 1969) , and other cellular mechanisms induced by herpesvirus infection can result in tumor formation (Cavallin et al., 2014) . Herpesvirus-associated tumor formation is known in many disease systems, including reptilian hosts. Of the reptilian herpesviruses, Alphaherpesviruses in testudinids are phylogenetically basal (McGeoch et al., 2006) . This old lineage of herpesvirus is diverse, with novel divergent strains found across numerous host species (Sim et al., 2015; Bicknese et al., 2010; Ossiboff et al., 2015) : one of which is strongly associated with tumor formation.
Fibropapillomatosis (FP) is the only known example of a widespread herpsvirus-associated tumorigenic disease in a reptile. FP is a neoplastic tumor disease of marine turtles that presents as fibropapillomas of the epidermal tissues, and fibromas of the internal organs (Herbst, 1994) . Most affected individuals are neritic (coastal) juveniles and subadults, with FP prevalence declining prior to sexual maturity (National Research Council, 1990) . Tumors are benign, though biological processes such as digestion, locomotion, and vision may be seriously impaired via obstruction (Herbst, 1994; Brooks et al., 1994a) . Severe cases of FP have additionally been linked to increased risk of bacteremia (Brooks et al., 1994b) . While green sea turtles (Chelonia mydas) are most commonly affected by FP, all marine turtles are capable of contracting the disease (Herbst, 1994) . Despite the conservation implications this disease might have for these endangered and threatened species, there are still many unresolved questions pertaining to the disease ecology of FP and its marine turtle hosts.
The putative etiological agent of FP is Chelonid Alphaherpesvirus 5 (ChHV5) (Quackenbush et al., 1998) . A genome of 132,233 bp was sequenced and assembled, identifying ChHV5 as a novel genus within Alphaherpesvirus (Herbst et al., 2004) , and a suite of molecular markers facilitated numerous phylogenetic analyses (Ene et al., 2005; Greenblatt et al., 2005; Quackenbush et al., 2001) . Recently, efforts to culture ChHV5 were successful (Work et al., 2009) . Though viral evolution rates, ancient origins of the virus, and co-divergence with host species were demonstrated (Gerber et al., 1969) , ecological and genetic variables important for disease progression are still being studied. ChHV5 was initially implicated in FP via histological investigations (Jacobson et al., 1991) . These results were further confirmed with the advent of sequencing technology, as fibromas are consistently found to harbor ChHV5 viral DNA (Quackenbush et al., 1998) . However, transmission pathways for this virus are still largely unknown, with hypotheses ranging from mechanical, vertical, and leech vectored, though cell-free extract has proven infectious in cell cultures (Herbst et al., 1995) .
Most investigations interested in sequence data from ChHV5 rely on samples sourced from tumors or the skin immediately adjacent to tumors (Ene et al., 2005; Patrício et al., 2012) . The high concentration of viral DNA in these tissues simplifies the process of amplification, making them attractive targets. Conversely, investigations interested in presence or absence of ChHV5 in asymptomatic animals by necessity utilize non-tumorous tissues, where lower viral concentrations have required the use of more intensive amplification efforts via nested PCR to enhance the likelihood of detection (Herrera et al., 1998; Lu et al., 2000) . Detection of ChHV5 in healthy turtles is often as low as 15%, though disentangling low asymptomatic carriage from low probability of detection (i.e., false negatives) remains challenging (Alfaro-Núñez et al., 2016) . Due to the differing methods employed in ChHV5 sequencing and detection studies, there is a paucity of information pertaining to viral sequence variation in asymptomatic hosts, save for a few notable studies (Alfaro-Nunez et al., 2014; Page-Karjian et al., 2015) . However, such investigations are necessary for understanding the relationship between viral infection and FP, as viral variation may explain why asymptomatic and tumorous hosts can both arise following ChHV5 infection.
Asymptomatic carriers of ChHV5, by definition, cannot be distinguished from non-carriers without molecular analyses and extensive sample collection, presenting a challenge for understanding viral dynamics outside of tumorous hosts. Additionally, asymptomatic tissue often produces inconsistent gene amplification results across viral loci, ostensibly due to low viral DNA concentrations (Page-Karjian et al., 2012) . Intensive sampling efforts of many individual turtles are therefore necessary to ensure adequate numbers of sequences for downstream analyses. However, most ChHV5 sequencing studies sample only a few individuals due to challenges associated with sampling large numbers of sea turtles, and consequently do not obtain a large number of viral sequences (Stacy et al., 2008; Rodenbusch et al., 2012) . Limitations on sample size is thus a major ongoing challenge for understanding ChHV5 epidemiology in juvenile sea turtles.
Here, we utilize a robust long-term dataset characterizing FP in juvenile marine turtles from 1983 to the present in a well-documented juvenile developmental habitat, the Indian River Lagoon adjacent to the central Atlantic coast of Florida, USA (Abreu-Grobois et al., 2000) . This dataset, collected by the University of Central Florida Marine Turtle Research Group (UCF MTRG), represents one of the longest in-water studies for juvenile C. mydas and loggerhead (Caretta caretta) sea turtles in the US. An average of 145 C. mydas juveniles are captured annually, and approximately half of these turtles have visible tumors (Hirama and Ehrhart, 2007) . We sampled normal skin, blood and tumors (when present) from asymptomatic and symptomatic C. mydas and C. caretta turtles over twenty years (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) 
Material and methods

Study site and sample collection
We collected tissue samples from all C. mydas and C. caretta captured during bi-monthly in-water sampling trips in the Indian River Lagoon (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) . These species regularly occur sympatrically both in this site and throughout their respective ranges, and are known to hybridize (James et al., 2004) . Our study site is located approximately 1-2 km south of the Sebastian Inlet within the Indian River Lagoon, Florida (27.8324°N; 80.4420°W). Turtles were captured by large-mesh tangle nets during bi-monthly sampling trips. Nets were set for approximately three hours per sampling session, and tended continuously by boat while soaking. Captured turtles were immediately brought onboard and transferred to a larger work-up boat. Turtles were tagged with flipper and PIT (Passive Integrated Transponder) tags, and standardized morphometrics and weights were collected from each turtle (Bjorndal et al., 1999) . Any tumor-like growths indicative of FP were photographed and documented using a standardized scoring system (Balazs and Pooley, 1991) : Category 0 -no symptoms, Category 1 -mildly afflicted, Category 2 -moderately afflicted, and Category 3 -severely afflicted. Category scores are subjectively determined by the size, number, and location of the tumors present on the turtles (Work and Balazs, 1999) and the majority of animals with FP in this study were Category 1. Blood was drawn from the dorsal cervical sinus of each turtle into evacuated blood collection tubes using antiseptic protocol and 20-gauge or 22-gauge needles depending on size of the turtle. We collected tissue biopsies following protected species permitted protocols. Each asymptomatic turtle (without FP) was sampled singularly. Any turtle with FP had an additional tissue biopsy taken directly from the most severe tumor observed in order to compare herpesvirus presence and quantity in tumorous versus non-tumorous tissue. The area biopsied was first scrubbed with an isopropyl alcohol swab. The skin biopsy was obtained using a 4-mm sterile biopsy punch. If needed, a coagulant powder was used to control bleeding after tissue sampling. Non-tumor skin samples were taken from the fleshy (non-scale) portion of the trailing edge of one of the rear flippers. For turtles with FP, a tumor skin sample was collected from the surface of the tumor (i.e., not digging down, but going across the tumor with one side of the biopsy punch, to avoid excessive bleeding). Tissue samples were preserved in 70% ethanol (skin and tumor) or heparinized tubes and transported to the laboratory where they were stored at −20°C. All captured turtles were released in the vicinity of their capture.
DNA extraction
A total of 566 samples were extracted utilizing Qiagen DNeasyTM spin columns (Qiagen, Redwood City, California) with the recommended protocol. Approximately 5 mg of skin tissue or 10 µL of blood were utilized in each extraction. Samples were eluted to a standard volume of 200 µL in order to preserve viral comparisons across samples. Extracted samples were stored at −20°C for future analyses.
Quantitative PCR
Quantitative PCR was performed with primers, probes, and thermal cycler conditions targeting the pol gene of ChHV5 as previously described (Quackenbush et al., 2001 ). Reaction conditions were as follows: 8 µL Biorad SSoProbe Supermix (Biorad, Hercules, California), 1 µM each forward and reverse primers, 250 pM probe, with molecular H2O bringing the total reaction volume to 20 µL. Reactions were run on a Biorad CFX 96 thermal cycler, and compared to GeneBlock Standards (IDTDna, Coralville, Iowa) of known concentrations designed to be identical to the targeted pol region in order to quantify viral genome copy number. QPCR results were analyzed using the BioRad CFX software to determine qPCR efficiency, viral presence, and viral load (gene copies). Negative samples and known positives were included in reaction plates in order to confirm assay specificity and control for potential contamination. Reactions demonstrating a cycle of quantification (CQ) earlier than 38 were considered positive (a conservative approach versus the MIQE recommendation of CQ 40). Positive samples were run in duplicate to confirm results, and inconsistent results were run in triplicate and the majority result taken as true. Samples confirmed as positive were utilized for Sanger sequencing. To calculate significance between viral titres across species and tissue samples, duplicate runs were averaged and compared with a Welch's two sided t-test accounting for increased variance amongst highly infected tissue types (ie, tumors, α = 0.05) to determine significant difference between viral copy means.
PCR and sanger sequencing
Four loci representing partial gene fragments were targeted for sequencing efforts: 366 bp of DNA polymerase (pol), 333 bp of capsid maturation protein (cap), 309 bp of glycoproteinB (gly) and 711 bp of Serine Threonine Kinase (STK). Three previously designed nested PCR protocols for the target loci cap, pol, and glyb were utilized for all samples (Page-Karjian et al., 2012) , in addition to a non-nested PCR for STK. As nested PCR is shown to outperform qPCR in tests of detection in asymptomatic tissue (Herbst et al., 1995) , all 566 samples in the dataset, including those negative for qPCR were screened via nested assays. An additional five samples known to contain ChHV5 (MTRG, unpublished) sampled from the 1998 season were provided and included in downstream analyses. PCR reaction conditions were as follows: 1 × OneTaq standard reaction buffer (NewEngland Biolabs, Ipswich, Massachusetts), 200 µM dNTPs, .2 µM forward and reverse primers, .75 U One Taq DNA polymerase, with molecular H2O bringing final reaction volumes to 10 µL. For the first step of nested PCRs (cap, pol, glyb), 3 µL of sample were utilized. 1 µL of PCR product was utilized as template in the second step reaction. Thermal cycler conditions for nested PCR loci were as follows: denaturation for 5 min at 95°C, followed by 38 cycles of denaturation at 95°C for thirty seconds, annealing at 50°C for 30 s, extension at 72°C for one minutes with a final extension step of 72°C for two minutes. Thermal cycler conditions for Serine Threonine Kinase were identical, save for annealing at 62°C.
Amplicons were purified utilizing FastAP and Exonuclease I (FisherSci, Hampton, New Hampshire), and Sanger Sequenced at Eurofins Genomics (Louisville, Kentucky). Chromatograms were visualized and edited by eye in Geneious vs 9.1.6. Consensus sequences were aligned utilizing CLUSTALW (gap penalty: 15, extend penalty: 6.66). Sequencing revealed that all tumors were fixed at the same STK haplotype, thus STK was removed from downstream analyses. The three remaining genes were concatenated and aligned utilizing a similar approach.
Phylogenetic reconstruction
Models of evolution were determined in PartitionFinder v.2 (Lanfear et al., 2017) , SUPPLEMENTAL], partitioning the complete concatenated alignments by gene fragment and codon (3 genes x 3 codon positions for nine total partitions). Models of evolution were selected using Bayesian Information Criterion (BIC). Phylogenies were constructed for both the complete species-tree, as well as independent gene-trees for each locus. Phylogenies were rooted by use of Chelonid Aphlaherpesvirus 6 (LET), a closely related virus that also causes disease in marine turtles. Phylogenetic analyses were conducted via MCMC in BEAST v. 1.8.4 (Drummond et al., 2012) . Analyses were run for 10,000,000 iterations with the first 1000 trees (10%) discarded as burn in. Tracer v.1.6 (Rambaut et al., 2014) was used to visualize the convergence of independent chains and determine that effective sample sizes of our parameters were appropriate (> 100). Trees were summed in Tree Annotator (Drummond et al., 2012) , specifying the target tree as the sample with the maximum product of posterior clade probabilities. This tree was edited in Figtree v 1.4.3. Post processing was performed in InkScape 0.91.
Selection analysis
We tested for positive and negative selection using Hypothesis testing using Phylogeny (HyPhy) (Pond and Muse, 2005) implemented on the Datamonkey server (Pond and Frost, 2005) . Because selection analyses can be inaccurate in the presence of recombination (Kosakovsky Pond et al., 2006) , these analyses were only performed on the independent gene-trees for gly, pol, and cap and with the HyPhyselected nucleotide substitution models for each gene. We further tested for intragenic recombination using GARD (Genetic Algorithms for Recombination Detection) and SBR (Single Breakpoint Recombination), and we only conducted analyses on non-recombining blocks (Kosakovsky Pond et al., 2006) . We used PARRIS (PARtitioning approach for Robust Inference of Selection) to detect gene-wide selection (Delport et al., 2010) , as well as the six codon-based maximum likelihood approaches to test for site-specific selection, including FEL (Fixed Effects Likelihood), iFEL (internal-FEL), FUBAR (Fast Unconstrained Bayesian AppRoximation), REL (Random Effects Likelihood), SLAC (Single Likelihood Ancestry Counting), and MEME (Mixed Effects Model of Evolution), which only allows testing for positive selection. Significance was set at P-value < 0.05 or Posterior Probability > 0.99, depending on the statistical framework of the sitespecific method. Only codons that were found to be under significant positive selection based on at least two of the six site-specific tests were considered to have robust evidence of positive selection.
Population genetics
We constructed an independent haplotype network of the polymerase locus, the most frequently amplified locus across our dataset, in order to determine the non-recombining ancestry of viral lineages in this study. Population networks of this gene were built utilizing TCS (Clement et al., 2002) as implemented in PopArt (Leigh and Bryant, 2015) . Trait values were assigned based on species, tissue, year, and disease state of samples.
Results
Our final dataset was comprised of 357 and 96 samples of C. mydas and C. caretta respectively. Samples included blood (n = 139), skin (n = 282) and tumor (n = 32) tissues. A total of 64 out of 566 C. mydas and C. caretta tissue samples amplified using nested PCR for at least one of four ChHV5 loci (Table 1) , and produced high-quality Sanger sequences that were confirmed via homology to sequences in the NCBI nr database to be ChHV5. Viral detection using qPCR and nested PCR was uneven, with nested PCR outperforming qPCR across tissues, species and disease states (Table 2) . Overall, qPCR had 62.5% efficacy compared to nested pcr, but particularly suffered in cases of non-tumor tissues, with 35% efficacy across all asymptomatic individuals. Comparisons between species (C. caretta vs C. mydas) were nonsignificant, but across tissues, tumors displayed significantly higher viral titres than skin or blood (Welch two sided t-test, T 16 = 3.345, p = .0048, Fig. 1 ). Mean pairwise distances between all samples are reported (Table S1 ): all polymorphisms were substitutions, with no indels detected in our sequences.
The most credible tree (Fig. 2) of the entire dataset reconstructed two well-resolved ChHV5 clades with deep divergence. The derived clade contains two polytomies demarcated with moderate support, and includes an admixture of all sample types (species, tissue, disease state, and year). The basal clade shows extensive diversification between samples resulting in well-resolved tips, though no patterns emerged relating to temporal sampling, tissue type, host species or disease state.
While recombination is known to occur across the ChHV5 genome (Morrison et al., 2018) , it was not found to confound selection analyses within our three gene fragments. Using our conservative approach requiring consistent results across at least two codon-based statistical methods, selection testing of our independent gene trees identified one codon, amino acid position 100 in the glycoprotein B gene, that had a significant signal of positive selection acting on one viral clade (Fig. 3 , red branches). Tests of positive selection indicating selection at this codon (Table 3) were MEME (p = .011, ω > 100) and REL (Bayes Factor = 1293.340, dN/dS = 1.666). The well-supported clade in the glycoprotein B phylogeny where positive selection acted on codon 100 (posterior = 1) is sister to the clade containing most recovered ChHV5 lineages (Fig. 3) . While this smaller clade contains no lineages from tumorous samples, it only represents ChHV5 sampled from two C. mydas individuals, presenting a challenge for robust interpretation.
TCS network construction recovered five haplotypes, falling in two major groupings that were consistent with the phylogenetic tree (Fig. 4) . Viral haplotypes were shared across host disease state and tissue type. Haplotypes that were exclusive to disease type did not cluster together: the most closely related haplotype to these samples were haplotypes shared between diseased and asymptomatic samples.
Discussion
By leveraging a large, long-term dataset of juvenile sea turtles with and without FP, this study resolves an important knowledge gap between ChHV5 sequence data in asymptomatic versus symptomatic hosts. Simultaneously, this effort clarifies the effectiveness of different techniques currently employed in ChHV5 surveillance: nested PCR and qPCR. A principal goal of this study was to determine the efficiency of Table 2 Rates of detection for assays used in this study. Relative qPCR detection is the proportion of qPCR positives recovered compared to nested PCR positives. Denoted by the asterisk, tumor amplification was disproportionately more successful than other tissue types (95% CI 43.9-82.49% for tumors vs −4-15%/-3-27% for ski and blood respectively). previously used surveillance tools when specifically applied to low detection probability samples. Universally, nested PCR was a more competent diagnostic tool in recovering positives from our dataset, especially in cases of asymptomatic animals and tissues. The weak detection power from non-tumor samples is of particular importance because the qPCR protocol we utilized was specifically tailored with asymptomatic surveillance as a goal (Quackenbush et al., 2001; AlfaroNúñez et al., 2016 ), yet it is these samples in which the discrepancy between techniques is most profound. Despite repeated efforts with high quality reagents (BioRad SSoAdvanced Universal Probe Supermix), qPCR could not be optimized to efficiencies approaching that achieved by nested PCR. Fig. 2 . Phylogenetic reconstruction based on three concatenated loci (Pol, Cap, Gly), with outgrouping of C. mydas lung and eye herpesvirus spp. Solid circles on nodes denote posterior probabilities of 1. All values above 0.5 are reported. Purple and green tip labels indicate asymptomatic C. mydas and C. caretta respectively, while red and orange tip labels indicate diseased C. mydas and C. caretta, respectively. Tumor and blood are labeled as plus signs and triangles respectively -all remaining unlabeled samples are skin tissue. Phylogenies were constructed via Markov chain Monte Carlo (MCMC) sampling implemented in BEAST.
The discrepancy among detection techniques is likely because qPCR targets a single locus (polymerase) whereas nested protocols target multiple loci from each tissue sample, with a positive for any locus being indicative of a positive sample. When considering the polymerase gene in isolation as a target for viral detection, nested PCR continued to outperform qPCR in our study (qPCR efficacy versus polymerase nested PCR = 70%). Nested PCR thus combines a more sensitive assay with a multi-locus approach, explaining the markedly higher rates of detection both here and in the original study that developed this assay (Lu et al., 2000) . However, the pattern of enhanced detection from nested PCR was not absolute: in rare cases, weakly positive samples for qPCR were not recovered in nested assays. An important caveat is that, in contrast to nested PCR which provides sequence data that confirms unambiguously the presence of ChHV5, qPCR provides no viral sequence data. Both the MIQE qPCR guidelines (Bustin et al., 2009) and empirical disease detection studies (Flori et al., 2004) demonstrate the possibility of weakly positive qPCR results from negative samples resulting in false positives. Thus, a weakly positive qPCR result is potentially the result of spurious amplification, and without sequencing confirmation, we could not definitively consider these samples as positive, despite repeated nested PCR efforts on those samples. Spurious amplification of the qPCR product often resulted in final copy numbers of less than twenty copies even at the final cycle (CQ 40), preventing Sanger sequencing of this off-target product.
Using the sequencing data generated from nested PCR, we incorporated both asymptomatic and tumorous tissues from FP positive and negative individuals to determine if a viral genetic variation might explain patterns in disease ecology. Previous work indicates the need to include asymptomatic tissue in order to determine the role of pathogen genetic variation in disease susceptibility (Alfaro-Núñez et al., 2016) , and our study supports this need (Patrício et al., 2012) . Our results indicate that diversification of ChHV5 lineages from both asymptomatic and diseased origin is extremely limited, at least within the loci we analyzed. The large polytomy recovered in the concatenated phylogeny included samples from both C. caretta and C. mydas, and samples from 1998 ranging until 2017, indicating that this clade has remained relatively stable for two decades despite being shared across two host species. Additionally, all clades contained samples from asymptomatic and symptomatic hosts, indicating that viral lineage divergence may play a limited or even no role in disease onset. Notably, only the two poorly-supported, low-divergence polytomies contained samples from tumorous tissue, suggesting that more divergent lineages could be Fig. 3 . Phylogenetic reconstruction of Glycoprotein B, with branches under positive selection highlighted in red. Solid circles on nodes denote posterior probabilities of 1. All values above 0.5 are reported. Purple and green tip labels indicate asymptomatic C. mydas and C. caretta respectively, while red and orange tip labels indicate diseased C. mydas and C. caretta, respectively. Tumor and blood are labeled as plus signs and asterisks respectivelyall remaining unlabeled samples are skin tissue. Phylogenies were constructed via Markov chain Monte Carlo (MCMC) sampling implemented in BEAST. Signals of selection were detected using the Datamonkey suite of tools.
Table 3
All Glycoprotein B codons under positive selection. All codons were supported by significant BAYES factors via REL. Only one codon (100) was supported at multiple analyses (REL and MEME). Significant Bayes factor (REL)/posterior probability (FUBAR) and p-value (all other analyses) are bolded. Associated dN/dS (REL) and ω (MEME) for significant results are included, italicized. lower virulence lineages linked to lower rates of tumor formation. This is consistent with selection analyses that found positive selection acting only on a lineage without any ChHV5 samples from tumorous tissues. However, small sample sizes and low support values for many lineages within the phylogenies preclude any definitive interpretation. Low posterior support values correspond with the low genetic diversity within the gene fragments incorporated in this study. Therefore, further research, especially including a larger representation of the viral genome, will be necessary to fully resolve patterns of viral evolution and disease associations. Notably, the loci selected in this study are not likely to directly participate in disease onset and represent a nearly neutral cohort for phylogenetic reconstructions capturing viral demography. Were viral lineages diverging respective to their propensity to cause disease, accumulation of variation in neutral loci during this divergence would result in monophyly of these loci respective to the disease trait. The lack of such structure in our phylogeny is indicative that disease is not a trait specific to viral lineage. Future studies explicitly investigating previously implicated oncogenes may clarify relationships that are due to selective forces operating on the disease system (Ackermann et al., 2012) , and WGS data derived from newly developed techniques may clarify previously missed background diversification not represented in this dataset. Given the limited genetic tools currently available for ChHV5, such studies require the development of new resources. While the genome of ChHV5 is sequenced, whole-genome sequencing (WGS) requires isolated genomic tissue from cultured virus (Ackermann et al., 2012) , rather than the sparse viral genomic copies interspersed with many turtle genome copies present in tissue extractions from asymptomatic individuals. As whole genome library preparation recommends 500-800 ng of target DNA for successful preparation (NEB UltraNext, New England Biosciences), viral DNA from asymptomatic animals presents a challenge for WGS, as viral genome copies may be as low as a few dozen per microlitre in these samples. The advent of new tools, particularly target capture technology (Warr et al., 2015) , and singlecell sequencing (Nawy, 2014) are two approaches that should be implemented to improve our ability to conduct genome-wide analyses of ChHV5 lineages. Metagenomic surveys of asymptomatic and tumorous turtle tissues is also a powerful genomic approach that may further resolve whether other etiological agents, or ChHV5 in combination with other agents, are better predictors of FP than ChHV5 alone. In addition, the improvement of nested PCR and qPCR are also being explored, with enhanced detection rates reported in some cases (Alfaro-Núñez et al., 2016; Page-Karjian et al., 2015) .
Conclusion
Our data confirms the detectable presence of ChHV5 in three tissue types, including whole blood extractions. Our data indicate that lineage identity of ChHV5 are poor predictors for host disease state, tissue type, temporal effects, or host species. Based on the limited loci assessed here, it appears that the genetics of ChHV5 do not play a significant role in disease progression or diversification, especially as highly similar strains remained constant for the two decades of our sampling. Based on these data, it is likely that some host or environmental processes are at the heart of disease onset and progression.
